Spray Were News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Individuals treated with esketamine were more likely to reach remission and remain relapse-free at 8 weeks of treatment.

United statesReina benabouJanssen scientific affairsNew england journalVice presidentMedical affairsHead to study shows patientsTreatment resistant depression receivingSpray were